近几十年多发性硬化残疾里程碑风险变化:瑞典全国人群队列研究
该研究基于瑞典MS登记库7331例1995-2010年诊断患者,随访至2016年,采用Weibull模型分析发现:复发型MS患者每诊断年份延迟一年,持续EDSS 3.0、4.0、6.0风险分别降低3%、6%、7%,而进展型MS无显著变化。
要点
- 复发型MS患者达到EDSS 3.0、4.0、6.0的风险随诊断年份显著下降。
- 进展型MS患者残疾累积风险未见随时间改善。
- 更有效疾病修正治疗的使用可能是复发型MS风险下降的驱动因素。
核心结论
- 瑞典复发型MS患者达到主要残疾里程碑的风险在过去十年显著下降,而进展型MS无变化。
研究设计与样本
- 全国人群回顾性队列研究,纳入瑞典MS登记库中1995年1月至2010年12月诊断、至少记录2次EDSS评分的7331例患者。
- 随访至2016年12月,中位随访8.5年(四分位距4.7-13.8年),采用Weibull模型处理区间删失数据。
主要发现
- 复发型MS患者持续EDSS 3.0风险每诊断年份降低3%(HR 0.97,95%CI 0.96-0.97)。
- 复发型MS患者持续EDSS 4.0风险每诊断年份降低6%(HR 0.94,95%CI 0.93-0.95)。
- 复发型MS患者持续EDSS 6.0风险每诊断年份降低7%(HR 0.93,95%CI 0.91-0.94)。
- 进展型MS患者EDSS 3.0、4.0、6.0风险变化均无统计学意义(HR分别为1.01、1.00、1.00)。
关键数值与推荐
- 复发型MS持续EDSS 3.0:HR 0.97(95%CI 0.96-0.97);EDSS 4.0:HR 0.94(95%CI 0.93-0.95);EDSS 6.0:HR 0.93(95%CI 0.91-0.94)。
- 进展型MS持续EDSS 3.0:HR 1.01(95%CI 0.98-1.03);EDSS 4.0:HR 1.00(95%CI 0.98-1.02);EDSS 6.0:HR 1.00(95%CI 0.98-1.02)。
- 分析调整了性别、就诊次数、诊断延迟和发病年龄。
临床怎么用
- 对于复发型MS患者,临床可预期其达到残疾里程碑的风险较前下降,但需结合个体情况动态评估。
- 进展型MS患者残疾累积风险未见改善,提示该群体仍需有效治疗手段。
局限性
- 回顾性队列设计可能存在残余混杂。
- 仅纳入至少2次EDSS记录的患者,可能存在选择偏倚。
- 研究未直接验证更有效治疗与风险下降的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Clinicians' experience and findings from recent natural history studies suggest that multiple sclerosis (MS) may now be running a more slowly progressing course than before. OBJECTIVE: To investigate whether the risk of reaching MS disability milestones has changed over the last decade in Sweden. DESIGN, SETTING, AND PARTICIPANTS: A nationwide population-based retrospective cohort study. By April 2017, 12 512 patients with available information on demographics, MS phenotype, and date of MS onset and diagnosis were registered in the Swedish MS Registry of which 7331 patients with at least 2 recorded Expanded Disability Status Scale scores (EDSS) and diagnosed between January 1995 and December 2010 were included. No further exclusion criteria were applied. Patients were followed up until December 2016 with a median duration follow-up of 8.5 (interquartile range, 4.7-13.8) years. Statistical analysis began in April 2017. MAIN OUTCOMES AND MEASURES: Patients were followed up from MS onset date to the date of sustained EDSS 3.0, 4.0, and 6.0. To handle interval-censored observations, a Weibull model was fit, and the change in the risk of EDSS 3.0, 4.0, and 6.0 over calendar years was estimated and hazard ratios (HRs) with corresponding CIs were calculated. RESULTS: Of 7331 patients, 5196 (70.9%) were women, and the mean (SD) age at diagnosis was 38.3 (11.7) years. Adjusting for sex, number of clinic visits, diagnostic delay, and onset age, a 3% decrease per calendar year of diagnosis for the risk of sustained EDSS 3.0 (HR, 0.97; 95% CI, 0.96-0.97), a 6% decrease for the risk of EDSS 4.0 (HR, 0.94; 95% CI, 0.93-0.95), and a 7% decrease for the risk of EDSS 6.0 (HR, 0.93; 95% CI, 0.91-0.94) among patients with relapsing-onset MS was found. The trends were not significant for patients with progressive-onset MS (EDSS 3.0: HR, 1.01; 95% CI, 0.98-1.03; EDSS 4.0: HR, 1.00; 95% CI, 0.98-1.02; EDSS 6.0: HR, 1.00; 95% CI, 0.98-1.02). CONCLUSIONS AND RELEVANCE: Risk of reaching major disability milestones has significantly decreased over the last decade in patients with relapsing-onset MS in Sweden. Several factors could potentially be responsible for this observation. However, given that no change was seen in disability accrual of patients with progressive-onset MS and the absence of efficacious treatment option in this group, increased use of more efficacious disease-modifying treatments could be a possible driver of this change.
引用
- Beiki O, Frumento P, Bottai M, et al. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden. JAMA Neurol. 2019. PMID: 30882868. doi:10.1001/jamaneurol.2019.0330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。